Sarepta Therapeutics, Inc.
US ˙ NasdaqGS ˙ US8036071004

SecuritySRPT / Sarepta Therapeutics, Inc.
InstitutionWalleye Capital LLC
Latest Disclosed Ownership288,532 shares
Latest Disclosed Value $ 6,278,456
Walleye Capital LLC ownership in SRPT / Sarepta Therapeutics, Inc.

On May 13, 2026 - Walleye Capital LLC filed a 13F-HR/A form disclosing ownership of 288,532 shares of Sarepta Therapeutics, Inc. (US:SRPT) valued at $6,278,456 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 272,732 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of 5.79% during the quarter. The current value of the position is $4,685,760 USD.

Walleye Capital LLC has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options. The firm currently holds call options representing 55,800 of underlying shares valued at $1,214,208 USD and put options representing 52,000 of underlying shares valued at $1,131,520 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 288,532 15,800 5.79 6,278 6.97 0.0261
2026-05-08 2026-03-31 13F SAREPTA THERAPEUTICS COM 803607100 288,532 15,800 6,278 0.0261
2026-02-13 2025-12-31 13F SAREPTA THERAPEUTICS COM 803607100 272,732 115,952 73.96 5,869 94.27 0.0180
2025-11-14 2025-09-30 13F SAREPTA THERAPEUTICS COM 803607100 156,780 -279,445 -64.06 3,021 -59.50 0.0113
2025-08-13 2025-06-30 13F SAREPTA THERAPEUTICS COM 803607100 436,225 423,278 3,269.31 7,459 803.03 0.0290
2025-05-14 2025-03-31 13F SAREPTA THERAPEUTICS COM 803607100 12,947 8,515 192.13 826 53.53 0.0037
2025-02-13 2024-12-31 13F SAREPTA THERAPEUTICS COM 803607100 4,432 -5,453 -55.16 539 -56.40 0.0013
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 9,885 -25,777 -72.28 1,235 -78.10 0.0026
2024-08-14 2024-06-30 13F SAREPTA THERAPEUTICS COM 803607100 35,662 -4,317 -10.80 5,635 8.87 0.0100
2024-05-15 2024-03-31 13F SAREPTA THERAPEUTICS COM 803607100 39,979 -68,862 -63.27 5,176 -50.69 0.0092
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS COM 803607100 108,841 67,073 160.58 10,496 107.29 0.0222
2023-11-21 2023-09-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 41,768 31,032 289.05 5,063 311.96 0.0129
2023-11-14 2023-09-30 13F SAREPTA THERAPEUTICS COM 803607100 41,768 31,032 5,063 0.0130
2023-08-14 2023-06-30 13F SAREPTA THERAPEUTICS COM 803607100 10,736 -9,593 -47.19 1,229 -56.12 0.0045
2023-05-15 2023-03-31 13F SAREPTA THERAPEUTICS COM 803607100 20,329 -27,340 -57.35 2,802 -54.65 0.0420
2023-02-14 2022-12-31 13F SAREPTA THERAPEUTICS COM 803607100 47,669 47,669 6,177 0.1126
2022-08-19 2022-06-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 0 -53,361 -100.00 0 -100.00
2022-08-08 2022-06-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -53,361 0
2022-05-27 2022-03-31 13F/A-01 SAREPTA THERAPEUTICS COM 803607100 53,361 31,488 143.96 4,169 111.62 0.1114
2022-05-16 2022-03-31 13F SAREPTA THERAPEUTICS COM 803607100 53,361 31,488 4,169 0.0849
2022-05-27 2021-12-31 13F/A-01 SAREPTA THERAPEUTICS COM 803607100 21,873 17,626 415.02 1,970 401.27 0.0612
2022-03-03 2021-12-31 13F SAREPTA THERAPEUTICS COM 803607100 21,873 17,626 1,970 0.0492
2021-11-15 2021-09-30 13F SAREPTA THERAPEUTICS COM 803607100 4,247 4,247 393 0.0111
2021-08-16 2021-06-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -11,282 -100.00 0 -100.00
2021-05-17 2021-03-31 13F SAREPTA THERAPEUTICS COM 803607100 11,282 11,282 841 0.0487
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -11,111 -100.00 0 -100.00
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS COM 803607100 11,111 11,111 1,688 0.1855
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A SAREPTA THERAPEUTICS COM Call 55,800 -14.02 1,214 -13.04 n/a n/a n/a
2026-05-08 2026-03-31 13F SAREPTA THERAPEUTICS COM Call 55,800 1,214 n/a n/a n/a
2026-02-13 2025-12-31 13F SAREPTA THERAPEUTICS COM Call 64,900 16.10 1,397 29.62 n/a n/a n/a
2025-11-14 2025-09-30 13F SAREPTA THERAPEUTICS COM Call 55,900 -70.81 1,077 -67.10 n/a n/a n/a
2025-08-13 2025-06-30 13F SAREPTA THERAPEUTICS COM Call 191,500 31,816.67 3,275 8,515.79 n/a n/a n/a
2025-05-14 2025-03-31 13F SAREPTA THERAPEUTICS COM Call 600 -94.50 38 -97.13 n/a n/a n/a
2025-02-13 2024-12-31 13F SAREPTA THERAPEUTICS COM Call 10,900 -59.33 1,325 -60.41 n/a n/a n/a
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS COM Call 26,800 8.06 3,347 -14.57 n/a n/a n/a
2024-08-14 2024-06-30 13F SAREPTA THERAPEUTICS COM Call 24,800 127.52 3,918 177.68 n/a n/a n/a
2024-05-15 2024-03-31 13F SAREPTA THERAPEUTICS COM Call 10,900 165.85 1,411 257.22 n/a n/a n/a
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS COM Call 4,100 -40.58 395 -52.75 n/a n/a n/a
2023-11-21 2023-09-30 13F/A SAREPTA THERAPEUTICS COM Call 6,900 -68.92 836 -67.11 n/a n/a n/a
2023-11-14 2023-09-30 13F SAREPTA THERAPEUTICS COM Call 6,900 836 n/a n/a n/a
2023-08-14 2023-06-30 13F SAREPTA THERAPEUTICS COM Call 22,200 -10.84 2,542 -25.91 n/a n/a n/a
2023-05-15 2023-03-31 13F SAREPTA THERAPEUTICS COM Call 24,900 81.75 3,432 93.30 n/a n/a n/a
2023-02-14 2022-12-31 13F SAREPTA THERAPEUTICS COM Call 13,700 -32.51 1,775 -20.90 n/a n/a n/a
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS COM Call 20,300 2,244 n/a n/a n/a
2020-05-15 2020-03-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS COM Call 20,800 56.39 2,684 167.86 n/a n/a n/a
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS COM Call 13,300 1,002 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A SAREPTA THERAPEUTICS COM Put 52,000 -59.44 1,132 -58.99 n/a n/a n/a
2026-05-08 2026-03-31 13F SAREPTA THERAPEUTICS COM Put 52,000 1,132 n/a n/a n/a
2026-02-13 2025-12-31 13F SAREPTA THERAPEUTICS COM Put 128,200 107.11 2,759 131.38 n/a n/a n/a
2025-11-14 2025-09-30 13F SAREPTA THERAPEUTICS COM Put 61,900 -44.18 1,193 -37.13 n/a n/a n/a
2025-08-13 2025-06-30 13F SAREPTA THERAPEUTICS COM Put 110,900 12,222.22 1,896 3,226.32 n/a n/a n/a
2025-05-14 2025-03-31 13F SAREPTA THERAPEUTICS COM Put 900 -85.00 57 -92.18 n/a n/a n/a
2025-02-13 2024-12-31 13F SAREPTA THERAPEUTICS COM Put 6,000 -63.64 730 -64.61 n/a n/a n/a
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS COM Put 16,500 725.00 2,061 551.90 n/a n/a n/a
2024-08-14 2024-06-30 13F SAREPTA THERAPEUTICS COM Put 2,000 -64.91 316 -57.12 n/a n/a n/a
2024-05-15 2024-03-31 13F SAREPTA THERAPEUTICS COM Put 5,700 -66.27 738 -54.76 n/a n/a n/a
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS COM Put 16,900 196.49 1,630 136.09 n/a n/a n/a
2023-11-21 2023-09-30 13F/A SAREPTA THERAPEUTICS COM Put 5,700 -36.67 691 -33.01 n/a n/a n/a
2023-11-14 2023-09-30 13F SAREPTA THERAPEUTICS COM Put 5,700 691 n/a n/a n/a
2023-08-14 2023-06-30 13F SAREPTA THERAPEUTICS COM Put 9,000 -21.05 1,031 -34.44 n/a n/a n/a
2023-05-15 2023-03-31 13F SAREPTA THERAPEUTICS COM Put 11,400 267.74 1,571 291.77 n/a n/a n/a
2023-02-14 2022-12-31 13F SAREPTA THERAPEUTICS COM Put 3,100 -45.61 402 -36.35 n/a n/a n/a
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS COM Put 5,700 630 n/a n/a n/a
2020-05-15 2020-03-31 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS COM Put 7,700 450.00 994 846.67 n/a n/a n/a
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS COM Put 1,400 105 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.